According to a filing with the Securities and Exchange Commission on Monday, Destiny Wealth Partners reduced its holding in the iShares Biotechnology ETF (IBB) by 59,354 shares during the quarter. The …
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging
view original post